1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. TSCAN THERAPEUTICS INC
Tscan Therapeutics Inc XNAS: TCRX

Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and ...

Read More
2.09 0.27 (14.84%)
66.40% Fall from 52W High
3.1M
XNAS Volume
High volume+gain today

XNAS 01 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
20.3 / 100
Momentum Score
Technically Moderately Bullish
63.3 / 100
Analyst Price Target
9
1Yr Price target upside is 310%
7 analysts

22

S

6

W

1

O

3

T

SWOT Analysis

Tscan Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..